107 related articles for article (PubMed ID: 12687678)
1. High frequency of the Ala481Thr mutation of the P gene in the Japanese population.
Suzuki T; Miyamura Y; Tomita Y
Am J Med Genet A; 2003 May; 118A(4):402-3. PubMed ID: 12687678
[No Abstract] [Full Text] [Related]
2. Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients.
Suzuki T; Miyamura Y; Matsunaga J; Shimizu H; Kawachi Y; Ohyama N; Ishikawa O; Ishikawa T; Terao H; Tomita Y
J Invest Dermatol; 2003 May; 120(5):781-3. PubMed ID: 12713581
[TBL] [Abstract][Full Text] [Related]
3. A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2).
Kato A; Fukai K; Oiso N; Hosomi N; Saitoh S; Wada T; Shimizu H; Ishii M
J Dermatol Sci; 2003 May; 31(3):189-92. PubMed ID: 12727022
[TBL] [Abstract][Full Text] [Related]
4. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan.
Inagaki K; Suzuki T; Shimizu H; Ishii N; Umezawa Y; Tada J; Kikuchi N; Takata M; Takamori K; Kishibe M; Tanaka M; Miyamura Y; Ito S; Tomita Y
Am J Hum Genet; 2004 Mar; 74(3):466-71. PubMed ID: 14961451
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations of the P gene in type II oculocutaneous albinism (OCA2).
Spritz RA; Lee ST; Fukai K; Brondum-Nielsen K; Chitayat D; Lipson MH; Musarella MA; Rosenmann A; Weleber RG
Hum Mutat; 1997; 10(2):175-7. PubMed ID: 9259203
[No Abstract] [Full Text] [Related]
6. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
[TBL] [Abstract][Full Text] [Related]
7. A Korean case of oculocutaneous albinism type IV caused by a D157N mutation in the MATP gene.
Suzuki T; Inagaki K; Fukai K; Obana A; Lee ST; Tomita Y
Br J Dermatol; 2005 Jan; 152(1):174-5. PubMed ID: 15656822
[No Abstract] [Full Text] [Related]
8. Investigation of albinism genes in congenital esotropia.
Burdon KP; Wilkinson RM; Barbour JM; Dickinson JL; Stankovich JM; Mackey DA; Sale MM
Mol Vis; 2003 Dec; 9():710-4. PubMed ID: 14685142
[TBL] [Abstract][Full Text] [Related]
9. Oculocutaneous albinism in an isolated Tonga community in Zimbabwe.
Lund PM; Puri N; Durham-Pierre D; King RA; Brilliant MH
J Med Genet; 1997 Sep; 34(9):733-5. PubMed ID: 9321758
[TBL] [Abstract][Full Text] [Related]
10. A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population.
Yi Z; Garrison N; Cohen-Barak O; Karafet TM; King RA; Erickson RP; Hammer MF; Brilliant MH
Am J Hum Genet; 2003 Jan; 72(1):62-72. PubMed ID: 12469324
[TBL] [Abstract][Full Text] [Related]
11. OCA4: evidence for a founder effect for the p.D157N mutation of the MATP gene in Japanese and Korean.
Inagaki K; Suzuki T; Ito S; Suzuki N; Fukai K; Horiuchi T; Tanaka T; Manabe E; Tomita Y
Pigment Cell Res; 2005 Oct; 18(5):385-8. PubMed ID: 16162179
[TBL] [Abstract][Full Text] [Related]
12. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.
Passmore LA; Kaesmann-Kellner B; Weber BH
Hum Genet; 1999 Sep; 105(3):200-10. PubMed ID: 10987646
[TBL] [Abstract][Full Text] [Related]
13. Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2).
Spritz RA; Fukai K; Holmes SA; Luande J
Am J Hum Genet; 1995 Jun; 56(6):1320-3. PubMed ID: 7762554
[TBL] [Abstract][Full Text] [Related]
14. Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene.
Puri N; Durbam-Pierre D; Aquaron R; Lund PM; King RA; Brilliant MH
Hum Genet; 1997 Oct; 100(5-6):651-6. PubMed ID: 9341887
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online.
Oetting WS; Gardner JM; Fryer JP; Ching A; Durham-Pierre D; King RA; Brilliant MH
Hum Mutat; 1998; 12(6):434. PubMed ID: 10671067
[TBL] [Abstract][Full Text] [Related]
16. Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African-Americans.
Durham-Pierre D; King RA; Naber JM; Laken S; Brilliant MH
Hum Mutat; 1996; 7(4):370-3. PubMed ID: 8723691
[No Abstract] [Full Text] [Related]
17. The clinical spectrum of albinism in humans.
Oetting WS; Brilliant MH; King RA
Mol Med Today; 1996 Aug; 2(8):330-5. PubMed ID: 8796918
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the genes for oculocutaneous albinism type 1 and type 4 in the German population.
Zühlke C; Criée C; Gemoll T; Schillinger T; Kaesmann-Kellner B
Pigment Cell Res; 2007 Jun; 20(3):225-7. PubMed ID: 17516931
[No Abstract] [Full Text] [Related]
19. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis in a family with oculocutaneous albinism manifesting in the same generation of three branches.
Preising MN; Forster H; Tan H; Lorenz B; de Jong PT; Plomp AS
Mol Vis; 2007 Oct; 13():1851-5. PubMed ID: 17960121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
